Melinda Kliegman

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Transcription Factor

Health Insurance

Top Venues

ACS synthetic biology

This page only lists publications with an associated author ORCID identifier.

Publications

Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Correction to "Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States". ACS synthetic biology 13 (6) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology 13 (5) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Correction to "Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States". ACS synthetic biology 13 (6) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology 13 (5) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Correction to "Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States". ACS synthetic biology (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology 13 (5) (2024)
Melinda Kliegman, Manar Zaghlula, Susan Abrahamson, Jonathan H Esensten, Ross C Wilson, Fyodor D Urnov, Jennifer A Doudna
A roadmap for affordable genetic medicines. Nature (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Correction to "Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States". ACS synthetic biology (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology 13 (5) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology 13 (5) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Correction to "Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States". ACS synthetic biology 13 (6) (2024)
Arik Shams, Alexandria Fischer, Anastasia Bodnar, Melinda Kliegman
Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. ACS synthetic biology 13 (5) (2024)
Lea Witkowsky, Matthew Norstad, Audrey R Glynn, Melinda Kliegman
Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute. Gene therapy (2023)